Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics

被引:59
|
作者
Oncken, CA
Hardardottir, H
Hatsukami, DK
Lupo, VR
Rodis, JF
Smeltzer, JS
机构
[1] UNIV CONNECTICUT, CTR HLTH, DIV MATERNAL FETAL MED, DEPT OBSTET & GYNECOL, FARMINGTON, CT 06030 USA
[2] UNIV MINNESOTA, DEPT PSYCHIAT, MINNEAPOLIS, MN 55455 USA
[3] HENNEPIN CTY MED CTR, DIV MATERNAL FETAL MED, MINNEAPOLIS, MN USA
[4] GEORGIA PERINATAL MED PC, ATLANTA, GA USA
来源
OBSTETRICS AND GYNECOLOGY | 1997年 / 90卷 / 04期
关键词
D O I
10.1016/S0029-7844(97)00309-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To compare nicotine concentrations and fetal middle cerebral artery resistance indices (RIs) during 21-mg transdermal nicotine use with these values during maternal smoking. Methods: In this randomized, crossover study, participants smoked approximately 20 cigarettes daily and were between 24 and 36 weeks' gestation. Subjects were randomized to transdermal nicotine or to smoking ad libitum for 8 hours. One week later, they crossed over to the other condition. Maternal plasma nicotine concentrations and hemodynamic measurements were obtained before and after the onset of smoking or patch placement. Results: Area under the plasma nicotine concentration-time curve during patch use was similar to continued smoking (93 versus 89 ng-hour/mL, respectively) (P = .77). The mean (standard error [SE] change in the middle cerebral artery RI from baseline to 4 hours later was similar during patch use and smoking: -.002 (0.008) versus -.02 (0.015), respectively (P = .3). The study had greater than 80% power to detect a 25% difference in nicotine concentrations and a change of 2 standard deviations in the middle cerebral artery RI between conditions. An unexpected finding was that of a loss of fetal heart rate (FHR) reactivity in 5/8 tracings after patch placement versus 1/6 tracings after smoking (P = .12). The baseline FHR increased by a mean (SE) of 8 (4) beats per minute with loss of reactivity in the patch condition, compared with a decrease of 3 (3) beats per minute without loss of reactivity (P = .05). Conclusion: Eight-hour use of 21-mg transdermal nicotine yields nicotine concentrations and middle cerebral artery RIs similar to those produced by hourly smoking in pregnant smokers. (C) 1997 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:569 / 574
页数:6
相关论文
共 50 条
  • [2] Transdermal nicotine replacement in pregnancy: Maternal pharmacokinetics and fetal effects
    Wright, LN
    Thorp, JM
    Kuller, JA
    Shrewsbury, RP
    Ananth, C
    Hartmann, K
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 176 (05) : 1090 - 1094
  • [4] COMPARISON OF PLASMA NICOTINE CONCENTRATIONS FOR NICOTINE TRANSDERMAL SYSTEM (NTS), CIGARETTE-SMOKING AND NICOTINE POLACRILEX (NICOTINE GUM)
    GORSLINE, J
    BENOWITZ, NL
    ROLF, CN
    GUPTA, SK
    GARAUD, JJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 129 - 129
  • [5] Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment
    Gourlay, SG
    Benowitz, NL
    Forbes, A
    McNeil, JJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 51 (05) : 407 - 414
  • [6] Determinants of plasma concentrations of nicotine and cotinine during cigarette smoking and transdermal nicotine treatment
    S. G. Gourlay
    N. L. Benowitz
    A. Forbes
    J. J. McNeil
    European Journal of Clinical Pharmacology, 1997, 51 : 407 - 414
  • [7] High-dose transdermal nicotine and naltrexone: Effects on nicotine withdrawal urges, smoking, and effects of smoking
    Rohsenow, Damaris J.
    Monti, Peter M.
    Hutchison, Kent E.
    Swift, Robert M.
    MacKinnon, Selene V.
    Sirota, Alan D.
    Kaplan, Gary B.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2007, 15 (01) : 81 - 92
  • [8] The maternal and fetal physiologic effects of nicotine
    Lambers, DS
    Clark, KE
    SEMINARS IN PERINATOLOGY, 1996, 20 (02) : 115 - 126
  • [9] Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking
    Benowitz, NL
    Hansson, A
    Jacob, P
    HYPERTENSION, 2002, 39 (06) : 1107 - 1112
  • [10] THE USE OF TRANSDERMAL NICOTINE IN SMOKING CESSATION
    MULLER, P
    ABELIN, T
    EHRSAM, R
    IMHOF, P
    HOWALD, H
    MAULI, D
    LUNG, 1990, 168 : 445 - 453